AI Chat
Macro & News
Stocks
Alpha Lab
Utility
Menu
EN
Login
EN
Plunge Analysis
/
Syros Pharmaceuticals Inc.
/
2026-04-09
▼ PLUNGE
Syros Pharmaceuticals Inc.
-33.3%
SYRS
NASDAQ
Healthcare
2026-04-09
0
Close
0
Prev Close
-33.33%
Change
17.7x
Vol Ratio
Why It Plunged
No related news available.
Related News
Keros Therapeutics’ Smaller Reporting Status Cuts Disclosure Burden but May Weigh on Investor Appeal and Volatility
Tipranks
2026-03-06
NRx Pharmaceuticals, Inc. (NRXP) Stock Price, News, Quote & History
Ca.Finance.Yahoo
2026-03-07
Silo Pharma Rallies After Securing Key Patent Allowance - SILO Pharma (NASDAQ:SILO)
Benzinga
2026-04-07
Phio Pharmaceuticals Announces Agreement with U.S. cGMP Manufacturing Source for Drug Product, PH-762
Hk.Marketscreener
2026-03-30
U.S. Tariff and Trade Policy Risks Threaten Intensity Therapeutics’ Supply Chain, Costs, and Stock Valuation
Tipranks
2026-03-29
Technical Analysis
Signals
MACD Bearish
Below SMA20
Key Indicators
47.55
RSI (14)
0.00
SMA 20
0.00
Bollinger Lower
0.00
Bollinger Upper
0.00
Bollinger Mid
0.00
MACD
0.00
MACD Signal
0.00
MACD Hist
View Company
Back to Surge Stocks
Syros Pharmaceuticals Inc. Surged +-33.3% on 2026-04-09 — Analysis | Alpha Lenz